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Summary
Objective: To determine the steady-state of messenger RNA (mRNA) levels of syndecan-1 and syndecan-4 in cartilage samples and
chondrocytes derived from human osteoarthritic knee joints.
Methods: Steady-state levels of gene-specific mRNA (relative to â-actin) were measured by semiquantitative polymerase chain reaction
(PCR).
Results: RT-PCR allowed detection of syndecan-1 (for the first time) and syndecan-4 in both cartilage samples and articular chondrocytes
cultured as primary monolayers. The mRNA levels of syndecan-1 were reduced in cartilage tissue from heavily damaged compared to
normal-looking areas whereas those of syndecan-4 were significantly increased. In contrast, the expression of syndecan-1 was higher in
cultured chondrocytes derived from the fibrillated osteoarthritic cartilage than in cells obtained from intact cartilage, while the syndecan-4
message levels did not differ between the two sites.
Conclusion: The expression of the cell-surface syndecans 1 and 4 is altered during the osteoarthritic degradative process of the knee joint.
The discoordinate syndecan gene expression, which is probably related to the chondrocyte proliferation and clustering, may contribute to the
disorganization of the cartilage and the development of OA processes. Isolation and culturing the chondrocytes as monolayers dramatically
change the expression of these genes and cannot reflect the in situ condition. © 2000 OsteoArthritis Research Society International*Received 21 May 1998; accepted 22 July 1999.
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Syndecans are a family of cell-surface heparan sulfate
proteoglycans (HSPGs) comprising four members:
syndecan-1, -2, -3 and -4.1 All syndecans are trans-
membrane proteins with an N-terminal extracellular domain
that contains consensus sequences for 3 to 8 gly-
cosaminoglycan (GAG) chains, an internal hydrophobic
membrane-spanning domain and a short C-terminal cyto-
plasmic domain.1 The majority of GAG chains added to the
core proteins are of the heparan sulfate type although
syndecan-12 and syndecan-43 have been shown to bear
chondroitin sulfate also.
Accumulating evidences support the role of syndecans
as modulators of cellular activities, in morphogenesis as
well as in proliferation and differentiation (review in4 and5).
All these biological processes are influenced by a variety of
diffusible factors and insoluble matrix components. Many of
these effectors must bind to the heparan-sulfate chains on
the cell surface. Therefore, it has been proposed that
syndecans and specific signaling receptors act together as
co-receptors and that the resonse to the effector depends
on the level of cell-surface heparan sulfate, most of which
being provided by the syndecan family.1 Syndecan-1,34which is studied in most detail, binds to various
extracellular-matrix proteins, including types I, III and V
collagens, fibronectin, thrombospondin and tenascin. It
also binds to basic fibroblast growth factor (bFGF), a
member of the heparin-binding growth factors. The ability
of syndecans to bind matrix proteins suggests that syn-
decans participate in cell-matrix adhesion, in a manner
which appears different from that of receptors of the integrin
family.4–7 Syndecan-4 can also bind protein kinase C
and regulates its distribution and activity, suggesting that
syndecans may also couple to intracellular signaling
pathways.8
Consistently with their roles as modulators of cellular
activities, the syndecans exhibit changes in their expres-
sion during development and cellular differentiation but
variations are often associated also with normal tissue
remodeling or pathological changes in tissue organiz-
ation.4,9,10 Syndecan-1 expression has been shown to
change during skin-wound repair and in embryonic tissue
interactions during morphogenesis. Generally, transformed
cells display low levels of cell-surface heparan sulfate and
reduced syndecan-1 expression has been reported for
malignantly transformed cells.11–13
In spite of the ubiquitous localization of syndecans, little
is known about their distribution, their biological roles or
expression in pathological states of articular cartilage. So
far, it has been reported that cultured human articular
chondrocytes expressed five cell-surface proteoglycans,
syndecan-4 (amphiglycan), CD44, fibroglycan, glypican
and betaglycan, as estimated by Northern blotting analysis
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detected by this technique.14 Thus, there is no report
hitherto concerning the expression of syndecan-1 in articu-
lar chondrocytes and its alteration in human osteoarthritis
(OA). Given the above mentioned functions of these genes,
it is however reasonable to expect that their pattern of
expression could be related to the development of the OA
process. Indeed, such information on the cell surface of
articular chondrocytes could contribute to understand the
responses of these cells in the disease, particularly to
growth factors.
OA is characterized by cartilage erosion, due to exces-
sive production by the chondrocytes of matrix metallo-
proteases (MMPs), including collagenase and stromelysin.
Proinflamatory cytokines, such as interleukin-1 (IL-1) have
been shown to play prominent roles in cartilage matrix
degradation, as they induce transcriptional activity of
the MMP genes15,16 and depress the synthesis of the
cartilage specific macromolecules, collagen type II and
aggrecan.17–19 However, in early stages of OA, activation
of the chondrocytes and deposition of matrix components,
mainly proteoglycans, have been reported and interpreted
as an attempt of cartilage repair.20–22 Several in-vitro and
in-vivo findings have shown that local growth factors pro-
duced by the chondrocytes are likely to play a role in this
anabolic reaction. Among them, TGF-â might be the most
important to the function and maintenance of articular
cartilage, as suggested by its effects on chondrocyte differ-
entiation, its expression in articular cartilage in vivo23 and
its ability to counteract most of the IL-1 effects (reviewed
in24). Other growth factors, including IGF-1 and bFGF, may
also play additional roles in the maintenance of cartilage
homeostasis.25 However, the repair potentialities of the OA
cartilage are finally overflowed by the degradative process
and no treatment can stop or slow the progression of the
disease.
A much better understanding of the mechanisms under-
lying the responses of the chondrocytes to this network of
cytokines/growth factors and their subsequent phenotypic
alterations in OA would require studies on the pericellular
microenvironment of these cells, the chondron, the inter-
actions of its specific molecules and the cell-surface
heparan sulfate proteoglycans (review in26). This work is
aimed at addressing this deficit by studying the expression
of the mRNA encoding two of these cell-surface proteogly-
cans, syndecan-1 and syndecan-4, in human OA cartilage
and isolated chondrocytes.Materials and methods
SOURCE OF CARTILAGE SAMPLES
Articular cartilage samples were obtained from nine
patients at the time of total knee arthroplasty (ages 64–86
years; two males and seven females). Slices of tissue were
collected by scalpel-blade dissection from two areas: (a) a
nonfibrillated region which comprised the uncovered lateral
tibial plateau and lateral femoral condyle and (b) a severely
fibrillated region corresponding to the middle segment
of femoral condyle and the covered (referring to the menis-
cus proximity) medial plateaux. Nonfibrillated cartilage
appeared normal, with a glossy, white, smooth unbroken
surface, and corresponded to a modified Mankin score of
zero.27 In the second area, the cartilage surface was
yellowish, softened and showed fissuring and fibrillation
(modified Mankin score >4). The cartilage samples weredevoid of surrounding tissue and osteophytes were
excluded from this study.HISTOLOGIC STUDIES
Macroscopic data were validated by histologic studies
performed on small, full thickness specimens cut from
comparative samples. They were fixed with 10% formalin,
decalcified, and embedded in paraffin. Sagittal sections
were prepared and stained with hematoxylin-eosin-safranin
O.ISOLATION AND CULTURE OF CARTILAGE CHONDROCYTES
The specimen was transferred to the laboratory in
Dulbecco’s Modified Eagle Medium (DMEM, Gibco/BRL,
France) containing antibiotics (100 units/ml penicillin,
100 ìg/ml erythromycin) and an antimycotic (0.25 ìg/ml
fungizone). Slices of normal-looking and altered cartilage
were cut aseptically, as thick as possible, excluding the
subchrondral bone, and kept in Earle’s Balanced Salt
Solution. Chondrocytes were released by enzymatic treat-
ment at 37°C: protease type XIV from Sigma (4 mg/ml) for
1.5 hours and collagenase type I (1 mg/ml, Sigma) over-
night. Isolated chondrocytes (approximately 20×106 cells
per area) were resuspended in DMEM in the presence of
10% FCS (fetal calf serum, Gibco/BRL, France) and anti-
biotics, seeded at high density (7.5×106 cells per 75 cm2
flask, corresponding to 105 cells per cm2) in order to
prevent cell dedifferentiation, and allowed to grow in mono-
layer culture at 37°C in a 5% CO2 atmosphere, with
medium change every 2–3 days. After reaching 80% con-
fluency, the cultures were used for total RNA preparation.RNA EXTRACTION
Total RNA from the chondrocyte cultures were extracted
by the guanidium isothiocyanate-phenol-chloroform pro-
cedure,28 using the RNaxel kit (Eurobio, France). Total
RNA was quantified by measuring the OD260 and the
integrity was checked by 1% agarose/formaldehyde gel
electrophoresis. Poly A+ mRNA was preferentially isolated
from the cartilage samples to avoid interference of proteo-
glycans with the classical RNA extraction protocol. Briefly,
cartilage slices were frozen in liquid nitrogen and poly A+
mRNA was extracted by a magnetic bead separation tech-
nology, using the Dynabeads mRNA DIRECT kit (DYNAL,
Norway). In that case, spectrophotometric determination of
the sample concentrations was not possible because of the
small amount of poly A+ mRNA obtained. To eliminate a
possible interference with contaminating genomic DNA,
RNA samples were treated in the absence of reverse
transcription step and shown to yield no product.SELECTION OF PCR PRIMERS
The oligonucleotide primer chosen are listed in Table I,
together with the length of the product to be derived from
the authentic message. The sequences selected14 are
located within the published human cDNA sequences
for syndecan-129 and syndecan-4.30 Syndecan-1 and -4
primers were chosen in their extracellular domain,
corresponding to the most specific fragment of these
proteoglycans. The primers for â-actin were designed from
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ANALYSIS
Reverse transcription was performed in a 50 ìl reaction
mixture containing 5 ìl of poly A+ mRNA preparation
(cartilage extracts) or 3 ìg of total RNA (chondrocyte
culture extracts), 1 ìl of oligo d(T)16 (20 ìM), 1 ìl of
Recombinant Ribonuclease Inhibitor RNAseOUT (40 units/
ìl), 10 ìl of 5× first strand buffer containing 15 mM MgCl2,
3 ìl of dNTPs (10 mM each) and 0.7 ìl of Moloney murine
leukaemia virus (MMLV) reverse transcriptase (200 units/
ìl) incubated at 42°C for 15 min, heated to 99°C for 5 min
and then chilled on ice for 5 min. Two microliters of the RT
reaction mixture were subjected to PCR using Taq DNA
polymerase in the presence of specific upstream and
downstream primers [4 ìl of 10× PCR buffer (200 mM
Tris–HCl pH 8.4, 500 mM KCl), 1.5 ìl of 50 mM MgCl2,
1 ìl of dNTPs (10 mM each), 1 ìl of specific upstream
primer (20 ìM), 1 ìl of specific downstream primer (20 ìM),
0.2 ìl of Taq DNA polymerase (15 units/ìl) and 29.3 ìl of
DEPC-treated water]. For all reported experiments, con-
ditions were determined to be in the linear range for both
the PCR amplification and the image analysis system.
Briefly, for each group of samples (i.e. RNA from altered
cartilage and apparently undamaged cartilage) all the
samples were subjected at the same time and subse-
quently, all samples of cDNA in a group amplified by PCR at
the same time to avoid any potential experiment to exper-
iment variation in efficiency (Fig. 4). Each RT sample was
assessed for â-actin (housekeeping gene) cDNA using 2 ul
of the 50 ul total volume of RT.
After increasing number of PCR cycles, a plot was done
for each sample and the transcript values corresponding
to the linear part of the amplification curve were used
to quantitate the messages versus the â-actin signal
determined in the same way.ANALYSIS OF PCR PRODUCTS
PCR products were analyzed in 2% agarose gels,
stained with ethidium bromide, and photographed (Polaroid
665 film). The negative film was used to measure the band
densities. A digital image was then analyzed, using a
scanner (Studioscan Ilsi, AGFA), and computer software
programs (FotoLook and Adobe Photoshop). Densities of
the bands were measured using the ImageQuant computersoftware program. Relative expressions of syndecan-1 and
-4 were calculated as the ratio to â-actin signal. Student’s
paired t test (two-tailed) was used to determine the signifi-
cance of the difference between the group of samples.RESTRICTION ENDONUCLEASE DIGESTION
The authenticity of PCR products was analyzed by
restriction endonuclease digestion using respectively Pvu II
and Bgl II (Gibco, BRL). One hundred microliters of PCR
products were precipitated by ethanol in the presence of
sodium acetate and recovered with 17 ìl H2O, 2 ìl of
respective buffer and 1 ìl of appropriate endonuclease.
Incubation was performed for 1 h at 37°C and the products
were analyzed on a 2% agarose gel. Pvu II endonuclease
cleaves the 560 bp syndecan-1 product generating frag-
ments of 391 and 169 bp, Bgl II cleaving also at a single
site the 347 bp syndecan-4 product into two fragments of
100 and 247 bp.ResultsCARTILAGE HISTOLOGY
The most difficult question in working with OA cartilage
samples is the heterogeneity of the samples. We wanted
to compare heavily damaged OA areas to apparently non-
fibrillated regions of the tissue, excluding samples with
moderate changes and, therefore, any correlation of bio-
chemical data to progressive degrees of cartilage injury.
Weight bearing areas of the medial femoral condyles
correspond generally to the predominant loss of cartilage
but there are still severely degraded areas at the margins
which can be used for analysis. Nonfibrillated cartilage was
taken from apparently intact, bright areas of the surface
(Fig. 1). Small pieces of corresponding areas were col-
lected at the same sites and used for histologic analysis.
The cases in which the macroscopic and microscopic
evaluations did not match were discarded. Unaltered carti-
lage appeared histologically comparable to healthy carti-
lage generally obtained from normal joints whereas all
degraded cartilage samples corresponded to advanced
stages of fibrillation.
Representative light micrographs of normal-looking
and damaged OA cartilage are shown in Fig. 2. Surface
deterioration is clearly visible in the OA specimen
(fibrillation), together with clustering of the chondrocytes.the published sequence.31 All primers were synthesized on
an Oligo 1000 DNA synthesizer (Beckham).Table I
Oligonucleotide primers used for RT-PCR. Primers are represented in a 5 ¢ to 3 ¢ orientation, with that for the
coding strand (+) being above that for the non-coding strand (−). The location of each primer within the cDNA
sequence is indicated, together with the product size generated by reverse transcription and PCR amplification
of the authentic mRNA
Molecule Primers Strand Location Message size Reference
Syndecan-1 CCCTGAAGATCAAGATGGCTCT + 295/316 560 14
CCCGAGGTTCAAAGGTGAAGT - 834/855
Syndecan-4 CTCCTAGAAGGCCGATACTTCT + 93/114 347 14
GGACCTCCGTTCTCTCAAAGAT − 419/440
b -actin GTGGGGCGCCCCAGGCACCA + 105/124 548 31
CTCCTTAATGTCACGCACGATTTC − 630/653
Osteoarthritis and Cartilage Vol. 8 No. 1 37PRESENCE OF SYNDECAN-1 AND -4 MESSAGES IN CARTILAGE
SAMPLES AND CULTURED CHONDROCYTES
Because of the low density of cartilage tissue and the
small size of OA samples available for multiple assays, we
used the RT-PCR amplification method instead of Northern
hybridization or RNAse protection assay which were not
sensitive enough to reveal syndecan-1 expression. We first
determined if the presence of syndecans 1 and 4 could be
detected in cartilage tissue. As can be seen in Fig. 3A, both
syndecan-1 and syndecan-4 mRNA messages were clearly
revealed by RT-PCR in apparently normal as well as
altered cartilage areas from OA patients. Primary cultures
of the chondrocytes were also analyzed in the same way to
ensure that the isolated cells were still capable of express-
ing the syndecans when seeded as monolayers. The data
on Fig. 3B, confirmed that the messages for syndecan-1
and syndecan-4 were present in cultured chondrocytes
derived from both unaltered and heavily-damaged cartilage
areas. Freshly isolated cells, before plating, were also
shown to express both syndecans (not shown). To control
the authenticity of the PCR products, the transcripts were
digested by restriction endonuclease enzymes. The Fig. 3C
shows that treatment with Pvu II endonuclease generated
the 391 and 169 bp fragments expected for syndecan-1
transcript. Similarly, digestion of the syndecan-4 product
with Bgl II enzyme yielded the corresponding 247 and
100 bp fragments.SEMIQUANTITATIVE RT-PCR MEASUREMENT OF SYNDECAN
MESSAGES IN OA CARTILAGE TISSUE
To compare the message levels of each syndecan in
unaltered and damaged areas of the osteoarthritic tibial
plateaux, we used a semiquantitative RT-PCR method.
Copy numbers of syndecans 1 and 4 in one ìg of total or
poly A+ RNA extracts vary widely among the samples. This
may be due to variations in either the isolation and purifi-
cation procedure, the cell number in different samples, or
the metabolic rates of the chondrocytes. So, the data were
normalized versus the â-actin mRNA level of each sample,assuming that the message of this conventionally accepted
‘house-keeping gene’ was relatively constant on a per cell
basis. These data were used to calculate the average
message levels of syndecans in each sample group
(normal-looking and damaged areas). We have also
ensured that the amplification efficiency for each message
was the same in intact versus fibrillated cartilage extracts
(Fig. 4). A representative mRNA analysis is shown, in which
a serial number of cycles were performed to establish the
amplification linear portion of the curve for both syndecans
and â-actin (Fig. 5). The procedure was reproduced on 3
different samples, for both syndecan-1 and syndecan-4,
with always the same findings (Table II). It is apparent that
the message for syndecan-1 relative to that of â-actin was
found lower for cartilage tissue from damaged than from
intact areas. In contrast, syndecan-4 message was clearly
higher in the fibrillated compared to normal-looking
samples (P<0.01).LEVELS OF SYNDECAN MESSAGES IN CULTURED CHONDROCYTES
FROM INTACT AND DAMAGED AREAS
We then analyzed the expression pattern of syndecans 1
and 4 in primary monolayer cultures of chondrocytes iso-
lated either from macroscopically and histologically intact
part of the tibial plateau or from heavily damaged areas. Six
donors were studied for syndecan-1 and four for
syndecan-4. A typical analysis is represented in Fig. 6. All
the damaged areas of cartilage showed greater amounts of
syndecan-1 mRNA than intact parts (P<0.01) (Table III).
The levels of syndecan-4 mRNA were apparently similar in
both intact and fibrillated areas. These results appeared
different from those obtained directly on cartilage extracts,
demonstrating that adhesion of the articular chondrocytes
on culture dishes induced a novel pattern of syndecans 1
and 4 expression.Fig. 1. The cartilage regions sampled for analysis. For both tissue analysis and chondrocyte cultures, cartilage from macroscopically
degenerated (‘maximal damage areas’) and apparently intact regions (‘unaltered areas’) were removed using a scalpel blade and submitted
to RNA extraction of enzymatic cell isolation (see Materials and methods). Samples corresponding to the same areas were also removed and
fixed in 10% formalin (pH=7.0) for standard light microscopic examination (see Fig. 2).Discussion
In contrast to the well-characterized functional properties
of aggrecan, and to some extent those of the other small
38 P.-E. Barre et al.: Semiquantitative reverse transcription-polymerase chain reaction analysisFig. 2. Representative light micrographs of intact (A) and damaged osteoarthritic (B) articular cartilage from tibial plateaux at low (1, 2) and
high (3, 4) magnification. In altered cartilage, surface deterioration is clearly visible as well as numerous clusters of chondrocytes.proteoglycans of the cartilage matrix (decorin, biglycan,
and fibromodulin), very little is known about the structure,
regulation and functions of the cell-surface proteoglycans
of articular chondrocytes. The only available data has
revealed the presence of syndecan-4 (amphiglycan), CD
44, fibroglycan and glypican messages in human normal
articular chondrocytes.14 However, the Northern-blotting
method used in that study failed to detect syndecan-1.Here, we estimated for the first time to the message levels
of syndecans 1 and 4 in human OA articular cartilage and
isolated chondrocytes, using a semiquantitative RT-PCR
procedure to compare intact and fibrillated areas.
The simultaneous assessment of samples derived from
areas with severe osteoarthritic injury and areas apparently
normal in the same joint allowed an internal comparison for
each patient while eliminating the risk that the variability in
Osteoarthritis and Cartilage Vol. 8 No. 1 39Fig. 3. Presence of syndecans 1 and 4 in cartilage tissue and
chondrocyte culture. (A) RT-PCR analysis performed with poly A+
RNA extracted from intact (I) and damaged (D) areas of osteo-
arthritic cartilage. (B) RT-PCR analysis on total RNA from primary
monolayer cultures of chondrocytes derived from intact (I) and
damaged (D) areas. (C) Control of authenticity of the transcripts by
restriction endonuclease digestion. The PCR products were
treated with Pvu II (for syndecan-1 transcript) of Bgl II (for
syndecan-4 transcript) endonucleases. Digestion yielded the frag-
ments of expected sizes (391 and 169 bp for syndecan-1, 247 and
100 bp for syndecan-4).Fig. 4. Amplification efficiency of the different messages. The
linearity of the points between cycles 23–32 was assessed by
straight line regression. The R2 values indicate a high degree of
linearity along these points within this PCR cycle range. Parallel-
ism between the lines corresponding to intact (I) and damaged (D)
cartilage areas ensures that amplification efficiency is the same in
all the samples.OA lesions among the subjects studied might affect the
statistical tests. Our findings provide evidence that both
apparently intact and heavily damaged areas of OA carti-
lage, as well as their respective isolated chondrocytes
express mostly syndecan-4 message, but also syndecan-1
at a relatively lower level. Interestingly, the mRNA level of
syndecan-1 was found to be lower in cartilage extracts from
altered areas than in intact parts of the tissue, contrasting
with the syndecan-4 expression which was clearly elevated
in damaged samples. Since our knowledge on the structure
and functions of the cell surface heparan sulfate proteo-
glycans of chondrocytes is just at its beginning, it is difficult
to appreciate the pathological significance of the important
change observed in the relative expression of syndecans 1and 4 in OA damaged cartilage. However, from the data
established on other cell types and experimental models
in the recent years, we can formulate some working
hypotheses. OA is characterized by quantitative and quali-
tative changes in the cartilage ECM: different types of
collagens are synthesized32,33 and variations in aggrecan
and small dermatan-sulfate proteoglycans have been also
reported.34,35 Hence, it is conceivable that changes could
also affect the cell-surface properties of the chondrocytes,
resulting in the up-regulation of syndecan-4 expression and
the reduction of syndecan-1 level. If so, these changes
could reflect an altered sensitivity of the cells to signals
originating from the damaged extracellular matrix of OA
cartilage. As cell-surface proteoglycans bearing heparan
sulfate, syndecans can modulate the signal transduction
activated by several heparin-binding factors such as basic
40 P.-E. Barre et al.: Semiquantitative reverse transcription-polymerase chain reaction analysisFig. 5. Representative semiquantitative RT-PCR analysis of syndecan-1 and -4 message levels in cartilage samples of areas from an OA
patient. Poly A+ RNA was extracted with oligo dT magnetic beads, as described in Materials and methods, and used in RT-PCR for
increasing number of amplification cycles. â-actin message was also determined in the same conditions. After separation in a 2% agarose
gel and ethidium bromide staining, the intensity of the bands was evaluated and an amplification curve was established. Relative mRNA
levels of syndecans were determined by normalization to â-actin message, after selection of bands within the linear part of the amplification
curve.fibroblast growth factor (bFGF).1 Moreover, syndecan-1 is
known to bind via its heparan sulfate side chains to a
number of extracellular matrix proteins, including fibro-
nectin, fibrillar collagens, thrombospondin and tenascin
(see review in4). Thus, syndecan-1 has a putative function
both in anchoring cell to the surrounding ECM and as a
growth factor co-receptor influencing activation of various
receptor tyrosine kinases.1 Therefore, the down-regulation
of syndecan-1 in OA cartilage could represent a selective
response of the stressed chondrocytes to environmental
changes, similar to those described recently for the
integrins,33 that may play great roles in the activation,
proliferation and ECM synthesis of these cells. The differ-
ential modulation of syndecan-1 relative to syndecan-4suggests that they do not have the same functions at the
cell-surface of chondrocytes, perhaps because of differ-
ences in their glycosaminoglycan chain composition of their
degree of sulfatation. Syndecan-4, which represents the
major form of the syndecans at the chondrocyte surface,
has been shown to localize at focal adhesions in fibro-
blastic cell types, strongly suggesting an association with
the microfilament cytoskeleton.4,37,38 Interestingly, protein
kinase C (PKC) is a focal adhesion component in normal
cells39 and is also activated during cell-matrix adhesion.40
Its pharmacological activation induces the recruitment of
syndecan-4 into focal adhesions38 and provides the signal
for focal adhesion formation.41 All the recent data support
the concept that binding of ligands (heparin-bindingTable II
Relative syndecan-1 and -4 mRNA expression (normalized to b -actin expression) measured in intact (I) and
damaged (D) areas of cartilage
Patient Sex Age
(years)
Syndecan-1 Syndecan-4
I D D vs I I D D vs I
1 F 68 0.92 0.71 −22.8% 0.60 1.02 +70.0%
2 F 70 2.07 1.63 −21.3% 1.19 1.76 +47.6%
3 F 70 2.25 0.89 −60.4% 0.63 1.04 +65.1%
Osteoarthritis and Cartilage Vol. 8 No. 1 41Fig. 6. Representative semiquantitative RT-PCR analysis of syndecan-1 and -4 message levels in primary monolayer cultures of
chondrocytes isolated from intact and damaged cartilage areas. Total RNA was extracted from the cultures, as described in Materials and
methods and used in RT-PCR as in the same conditions as in Fig. 5.domains of matrix molecules) may induce activation of PKC
through a specific sequence of syndecan-4 V region.5
Therefore, it is tempting to speculate that the up-regulation
of syndecan-4 mRNA message in OA damaged cartilage, if
it is accompanied by correlated change at the protein level
(which remains to be demonstrated), may have a great
relevance to the pathophysiology of OA matrix cartilage, as
it is probably related to the activation of the chondrocytes,
their clustering and the novel interactions of these cells with
the profoundly altered ECM.20–22 If so, the changes in the
expression of syndecan-4 could influence the signaling
mechanisms of OA chondrocytes. For example, the proteo-
glycan expression could be significantly altered since PKChas been shown to play a role in the regulation mech-
anisms of these molecules.42–44 The PKC signaling
pathway seems also implicated in the modulation of
chondrocyte phenotype since inhibition of the enzyme by
staurosporine is capable of restoring the differentiated state
of these cells.45,46
Our data on cultured chondrocytes were not consistent
with the results obtained on cartilage extracts. Syndecan-1
appeared up-regulated in cells derived from heavily-
damaged samples compared to cells from apparently intact
areas whereas syndecan-4 expression was not signifi-
cantly changed. Taking that syndecans have great roles
in cell adhesion and spreading, it is not surprising thatTable III
Relative syndecan-1 and -4 mRNA expression (normalized to b -actin expression) measured in chondrocytes
derived from intact (I) and damaged (D) areas
Patient Sex Age
(years)
Syndecan-1 Syndecan-4
I D D vs I I D D vs I
4 M 67 0.51 0.76 +49.0%
5 F 86 0.97 1.34 +38.1%
6 M 72 0.44 0.63 +43.2% 0.57 0.58 +1.7%
7 F 68 0.30 0.44 +46.7% 0.52 0.53 +1.9%
8 F 76 0.25 0.39 +56.0% 0.41 0.45 +9.8%
9 F 64 0.57 0.83 +45.6% 0.41 0.42 +2.4%
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